English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45384/58560 (78%)
造訪人次 : 2509029      線上人數 : 176
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/6390


    題名: 承氣湯系方劑實證醫學與藥理作用探討
    A systematic review of clinical efficacy and investigations of pharmacological effects of three Chen-Chi-Tang decoctions
    作者: 曾頌惠
    Sung-Hui Tseng
    貢獻者: 藥學系(博士班)
    關鍵詞: 承氣湯
    瀉下
    抗發炎
    抗氧化
    降血脂
    減重
    Chen-Chi-Tang
    purgative
    anti-inflammatory
    anti-oxidative
    obesity
    日期: 2007
    上傳時間: 2009-09-11 16:53:54 (UTC+8)
    摘要: 中醫認為當邪在裡宜下,重必攻而下之,也就是運用通腑攻下之法去邪、恢復機體的平衡。本研究利用傷寒論中的大承氣湯、小承氣湯、及調胃承氣湯為研究對象,以現代醫藥研究法,探討此重要的中醫治療理論。以實證醫學的方法搜尋三承氣湯相關之文獻,了解三個方劑之臨床療效與差異。結果顯示此三種承氣湯(尤其是大承氣湯)具有促進腸胃功能之改善作用(證據等級為moderate級),但大黃或大黃複方應用於減重則是無效、應用於降血脂之臨床證據仍有爭議。再者,以現代瀉下、抗肥胖、降血脂、抗發炎與抗氧化研究方法,評估「瀉下清熱」之藥理作用。結果顯示大承氣湯確實具有較強的瀉下作用,且還具有抑制血中油脂急性增加的作用。小承氣湯瀉下作用確實較大承氣湯弱,但可降低因較長期服用高脂飼料所導致的高膽固醇症。但是三種承氣湯皆無降低體重的效果。「清熱」機制的藥理研究部分顯示大承氣湯具有最強的抗發炎效用,可抑制發炎介質的表現,如nitric oxide (NO)、prostaglandin E2(PGE2)、 iNOS等的表現,因此大承氣湯在非腸胃型之發炎模式中也有很好的抗發炎反應。小承氣湯之抗氧化能力與保肝能力最顯著,推測是小承氣湯中總多酚含量、總類黃酮含量、 (+)-catechin的含量最多有關。傳統中醫利用三承氣瀉下的作用,清除?媦騿A恢復身體機能的平衡。本研究結果提供了三種承氣湯瀉下清熱的作用可能與具有抗發炎與抗氧化之機制有關。未來之臨床應用可朝發炎反應與氧化反應機能失衡的疾病去思考三種承氣湯的現代應用。
    So far, there are still many traditional Chinese medical theories and practices not supported with good enough scientific evidences. We are interested in the mechanism involved in purgation that traditional Chinese doctors used when their patients suffered with internal heat, stagnation, and fullness syndromes. Three Chen-Chi-Tang decoctions (CCTD), including Ta-Chen-Chi-Tang (TCCT), Xiao-Chen-Chi-Tang (XCCT), Tiao-Wei-Chen-Chi-Tang (TWCCT) are three famous purgative formulas In this study, we first conducted a systemic review for evaluating the clinical efficacy of these purgative decoctions on gastrointestinal problems and obesity and hyperlipidemia. We also designed many in vitro and in vivo studies in order to delineate the efficacy and underlying mechanisms involved in purgation. From the systemic review, there is moderate evidence to support the efficacy of CCTD (especially TCCT) in the management of gastro-intestinal problems, but most of the studies do not support anti-obesity effect of purgative decoctions, and clinical evidence of purgatives on hyperlipidemia is still controversial. Through in vitro and in vivo experiments, we have shown that TCCT is a potent anti-inflammatory agent, and XCCT is a potent anti-oxidantant. Inflammation and oxidative stress are two pathophysiological processes involved in many diseases suffered by modern man today. Future clinical application of CCTDs may based on these findings in order to improve the efficacy of these traditional Chinese medicine in the present world.
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc27KbMicrosoft Word174檢視/開啟
    摘要.pdf68KbAdobe PDF233檢視/開啟
    摘要.ppt96KbMicrosoft Powerpoint258檢視/開啟
    摘要.ps401KbPostscript87檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋